Cargando…
Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination
Remyelination is in the center of new therapies for the treatment of multiple sclerosis to resolve and improve disease symptoms and protect axons from further damage. Although remyelination is considered beneficial in the long term, it is not known, whether this is also the case early in lesion form...
Autores principales: | Schultz, Verena, van der Meer, Franziska, Wrzos, Claudia, Scheidt, Uta, Bahn, Erik, Stadelmann, Christine, Brück, Wolfgang, Junker, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518437/ https://www.ncbi.nlm.nih.gov/pubmed/28560740 http://dx.doi.org/10.1002/glia.23167 |
Ejemplares similares
-
Extensive subpial cortical demyelination is specific to multiple sclerosis
por: Junker, Andreas, et al.
Publicado: (2020) -
Experimental models of demyelination and remyelination()
por: Torre-Fuentes, L., et al.
Publicado: (2020) -
Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis
por: Lagumersindez-Denis, Nielsen, et al.
Publicado: (2017) -
Multiple Sclerosis and Aging: The Dynamics of Demyelination and
Remyelination
por: Correale, Jorge, et al.
Publicado: (2022) -
Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis
por: Zhao, Xinda, et al.
Publicado: (2023)